AVDL250516C12500
- 0.06
- 0.000.00%
Avadel Pharmaceuticals Newsroom
Avadel Pharmaceuticals Analyst Ratings
Leerink Partners Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $16
A Quick Look at Today's Ratings for Avadel Pharmaceuticals(AVDL.US), With a Forecast Between $19 to $22
Avadel Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
Craig-Hallum Sticks to Its Buy Rating for Avadel Pharmaceuticals (AVDL)
Avadel Pharmaceuticals Analyst Ratings
Deutsche Bank Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $12
Avadel Pharmaceuticals Analyst Ratings
Deutsche Bank Initiates Coverage on Avadel Pharmaceuticals With Buy Rating, $12 Price Target
Avadel Pharmaceuticals Analyst Ratings
UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $14
A Quick Look at Today's Ratings for Avadel Pharmaceuticals(AVDL.US), With a Forecast Between $13 to $22
Avadel Pharmaceuticals Is Maintained at Overweight by Piper Sandler
Avadel Pharmaceuticals Price Target Cut to $13.00/Share From $24.00 by Piper Sandler
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and ProQR (PRQR)
Avadel Pharmaceuticals Price Target Cut to $21.00/Share From $25.00 by HC Wainwright & Co.
Piper Sandler Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $13
Piper Sandler Keeps Their Buy Rating on Avadel Pharmaceuticals (AVDL)
H.C. Wainwright Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $21
Avadel Pharmaceuticals Analyst Ratings